Canbi Pharma Tech Limited
CAS 285978-18-9 | Uridine-13c9-15n2 5
285978-18-9 Uridine-13C9-15N2 5'-(tetrahydrogen Triphosphate) Sodium Salt
19817-92-6

CAS 285978-18-9 | Uridine-13c9-15n2 5'-(tetrahydrogen Triphosphate) Sodium Salt

Product name:Uridine-13C9-15N2 5'-(tetrahydrogen triphosphate) sodium salt
CAS:285978-18-9
MF:C9H13N2O15P3.2Na
MW:528.103
EINECS:2017-001-1
MDL No.:MFCD11101450

Send Inquiry
Description
Properties

Appearance: White to Off-White powder

Melting point:>199℃ (dec.)

Water Solubility Water : 125 mg/mL (231.90 mM; Need ultrasonic)

Stability:Hygroscopic

 

 

Market Applications  
1. mRNA & Nucleic Acid Therapeutics  substrate for in vitro transcription (IVT) to synthesize mRNA, siRNA, and viral RNA- Key raw material for mRNA vaccine and gene therapy manufacturing- Used in RNA amplification and aRNA synthesis workflows
2. Molecular Biology Research - Substrate for RNA polymerases in in vitro RNA synthesis- Precursor for UDP‑sugars (UDP‑glucose, UDP‑galactose) in glycosylation studies- Energy source and cofactor in enzyme assays for carbohydrate metabolism
3. Pharmaceutical & Drug Development - Intermediate for nucleotide‑based drugs (e.g., diquafosol ophthalmic solutions)- Agonist for P2Y₂/P2Y₄ receptors in cell signaling and drug screening- Component in diagnostic kits for ciliary dyskinesia and metabolic disorders

 

Package:

Our products generally use double-layer packaging to ensure product sealing and quality. Specific packaging can also be provided for the product according to customer requirements.

 

Synonyms:

285978-18-9

Uridine-5'-triphosphate disodium salt

Disodium;[[[(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-oxidophosphoryl]oxy-hydroxyphosphoryl] hydrogen phosphate

Uridine triphosphate 13C9,15N2 sodium

Sodium((2R,3S,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyldihydrogentriphosphate

 

Popular products:

Product Name CAS No.
2-NORBORNYL BROMIDE 29342-65-2
N-Ethyl-4-methoxybenzylamine 22993-76-6
2-METHYL-3,1-BENZOXAZA-4-ONE 525-76-8
2-Methyl-3-Amino-4-Quinazolone 1898-06-2
BETA-ELEMENE 515-13-9
(E,E)-GERANYL LINALOOL 1113-21-9
(E,E)-FARNESYL ACETONE 1117-52-8
1-BROMO-2,4-DIFLUORO-5-NITROBENZENE 345-24-4

 

 

About Us
Canbi Pharma Technology is a subsidiary of Chongqing Kalan Pharmaceutical Co., Ltd.(Also known as CONIER CHEM AND PHARMA LIMITED)
It was founded in the first economic and technological development zone in Southwest China. It is a young company focusing on the fields of organic chemistry and biological engineering. The company specializes in the development, production, and sales of chemicals, new materials, pharmaceutical intermediates, and APIs. The core team of the company comes from Sichuan University and it's West China medical center. They have received guidance and support from chemistry professors and experts from Sichuan University, the West China medical center of Sichuan University, and the ChongQing Medical University.

 

Hot Tags: CAS 285978-18-9 | Uridine-13c9-15n2 5'-(tetrahydrogen Triphosphate) Sodium Salt, China CAS 285978-18-9 | Uridine-13c9-15n2 5'-(tetrahydrogen Triphosphate) Sodium Salt manufacturers, suppliers, biochemical organ engineering, Glycoursodeoxycholi cacid, biochemical protein expression, Benztropine mesylate, 928-95-0, bio chemical substances

Inquiry
goTop

(0/10)

clearall